Literature DB >> 16879055

Haptoglobin polymorphism in patients with preeclampsia.

Herman T Depypere1, Michel R Langlois, Joris R Delanghe, Marleen Temmerman, Marc Dhont.   

Abstract

BACKGROUND: Haptoglobin (Hp) polymorphism has been associated with blood pressure regulation and essential hypertension. We investigated Hp polymorphism in patients with preeclampsia.
METHODS: A total of 60 Caucasian women with preeclampsia were prospectively followed from hospital admission until delivery. Serum Hp phenotypes 1-1, 2-1, and 2-2 were determined by starch gel electrophoresis and compared with those in 200 normotensive controls of the same geographic and ethnic origin. Blood pressure and laboratory markers (serum uric acid, alanine aminotransferase, aspartate aminotransferase, platelet count, and 24-h proteinuria) were compared according to Hp phenotypes of preeclamptic women.
RESULTS: We found a higher Hp1 allele frequency in the preeclamptic group than in normotensive controls (0.517 vs. 0.400, p<0.05). The Hp 1-1 phenotype was present in 28% of preeclamptic patients vs. 16% of the controls, with an odds ratio (95% CI) of 2.08 (1.05-4.08) for Hp 1-1 vs. the other Hp phenotypes. Diastolic (p<0.005) and systolic (p<0.05) blood pressure and proteinuria (p<0.05) were highest in Hp 1-1 patients. Other laboratory markers were not significantly different between Hp phenotype subgroups.
CONCLUSIONS: The Hp1 allele frequency was higher among preeclamptic patients and the Hp 1-1 phenotype was associated with more severe hypertension and proteinuria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879055     DOI: 10.1515/CCLM.2006.182

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Haptoglobin phenotype in women with preeclampsia.

Authors:  Rami N Sammour; Farid M Nakhoul; Andrew P Levy; Rachel Miller-Lotan; Nakhoul Nakhoul; Hoda R Awad; Ron Gonen; Gonen Ohel
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  Preeclampsia and diabetes.

Authors:  Tracey L Weissgerber; Lanay M Mudd
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

3.  Haptoglobin phenotype, angiogenic factors, and preeclampsia risk.

Authors:  Tracey L Weissgerber; James M Roberts; Arun Jeyabalan; Robert W Powers; Minjae Lee; Saul A Datwyler; Robin E Gandley
Journal:  Am J Obstet Gynecol       Date:  2012-01-13       Impact factor: 8.661

4.  Haptoglobin phenotype and abnormal uterine artery Doppler in a racially diverse cohort.

Authors:  Tracey L Weissgerber; Paula L McGee; Leslie Myatt; John C Hauth; Michael W Varner; Ronald J Wapner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Philip Samuels; Anthony C Sciscione; Margaret Harper; George Saade; Yoram Sorokin
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-13

5.  Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.

Authors:  Marie-Christine W Gast; Harm van Tinteren; Marijke Bontenbal; René Q G C M van Hoesel; Marianne A Nooij; Sjoerd Rodenhuis; Paul N Span; Vivianne C G Tjan-Heijnen; Elisabeth G E de Vries; Nathan Harris; Jos W R Twisk; Jan H M Schellens; Jos H Beijnen
Journal:  BMC Cancer       Date:  2008-12-24       Impact factor: 4.430

6.  Haptoglobin phenotype, pre-eclampsia, and response to supplementation with vitamins C and E in pregnant women with type-1 diabetes.

Authors:  T L Weissgerber; R E Gandley; J M Roberts; C C Patterson; V A Holmes; I S Young; D R McCance
Journal:  BJOG       Date:  2013-05-30       Impact factor: 6.531

7.  Haptoglobin phenotype, preeclampsia risk and the efficacy of vitamin C and E supplementation to prevent preeclampsia in a racially diverse population.

Authors:  Tracey L Weissgerber; Robin E Gandley; Paula L McGee; Catherine Y Spong; Leslie Myatt; Kenneth J Leveno; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Philip Samuels; Anthony Sciscione; Margaret Harper; Jorge E Tolosa; George Saade; Yoram Sorokin
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

8.  Polymorphism of haptoglobin in patients with premature rupture of membrane.

Authors:  Jin-Kyung Cho; Yeun-Hee Kim; In-Yang Park; Jong-Chul Shin; Mi-Kyung Oh; Seon-Joo Park; Nam-Hoon Kim; In-Sook Kim
Journal:  Yonsei Med J       Date:  2008-02-24       Impact factor: 2.759

9.  In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism.

Authors:  Andreia Matos; Alda Pereira da Silva; Maria Clara Bicho; Conceição Afonso; Maria José Areias; Irene Rebelo; Manuel Bicho
Journal:  Obstet Gynecol Int       Date:  2014-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.